Relyvrio Interactions
There are 588 drugs known to interact with Relyvrio (sodium phenylbutyrate/taurursodiol), along with 4 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 7 are major, 579 are moderate, and 2 are minor.
- View all 588 medications that may interact with Relyvrio
- View Relyvrio alcohol/food interactions (3)
- View Relyvrio disease interactions (4)
Most frequently checked interactions
View interaction reports for Relyvrio (sodium phenylbutyrate / taurursodiol) and the medicines listed below.
- acetaminophen
- Advil (ibuprofen)
- alpha-lipoic acid
- alprazolam
- amlodipine
- armodafinil
- Aspir 81 (aspirin)
- astaxanthin
- Ativan (lorazepam)
- atorvastatin
- baclofen
- bisoprolol / hydrochlorothiazide
- Curcumin 95 (turmeric)
- Dulcolax Stool Softener (docusate)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- levothyroxine
- Lexapro (escitalopram)
- losartan
- MiraLAX (polyethylene glycol 3350)
- NAC (acetylcysteine)
- Nuedexta (dextromethorphan / quinidine)
- pravastatin
- Radicava (edaravone)
- Radicava ORS (edaravone)
- Rilutek (riluzole)
- riluzole
- sertraline
- tizanidine
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Relyvrio alcohol/food interactions
There are 3 alcohol/food interactions with Relyvrio (sodium phenylbutyrate / taurursodiol).
Relyvrio disease interactions
There are 4 disease interactions with Relyvrio (sodium phenylbutyrate / taurursodiol) which include:
Report options
More about Relyvrio (sodium phenylbutyrate / taurursodiol)
- Relyvrio consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
